Company news

Champions Oncology, Inc. news in 2022

Champions Oncology, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

December 14, 2022

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

December 12, 2022

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

December 8, 2022

Submission of Matters to a Vote of Security Holders - Form 8-K

October 20, 2022

Submission of Matters to a Vote of Security Holders (form 8-K)

October 20, 2022

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

September 9, 2022

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

September 7, 2022

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022

September 5, 2022

Champions Oncology Reports Quarterly Revenue of $12.9 Million

July 20, 2022

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

July 13, 2022

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

May 30, 2022

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo

May 2, 2022

Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million

March 14, 2022

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022

March 10, 2022

Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors

February 14, 2022

Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates

January 19, 2022

Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs

January 3, 2022

Calls in 2022